P067 - How important is upgrading on biochemical recurrence and prognosis after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance?
Erdem, S., Ergul, R., Cetin, S., Tantekin, A., Ozluk, Y., Sanli, O., Ozcan, F.
Published in European urology open science (Online) (01.11.2023)
Published in European urology open science (Online) (01.11.2023)
Get full text
Journal Article
How important is upgrading on biochemical recurrence and prognosis after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance?
Erdem, S., Ergul, R., Cetin, S., Tantekin, A., Ozluk, Y., Sanli, O., Ozcan, F.
Published in European urology open science (Online) (01.11.2023)
Published in European urology open science (Online) (01.11.2023)
Get full text
Journal Article
P206 How is the efficacy of patient selection criteria for adjuvant pembrolizumab after curative surgical treatment of clear cell renal cell carcinoma with intermediate to high risk of recurrence? A real-life data analysis from single institutional experience
Erdem, S., Tantekin, A., Ozervarli, F., Ergul, R., Pazir, Y., Hurdogan, O., Ozluk, Y., Sanli, O., Ozcan, F.
Published in European urology open science (Online) (01.11.2024)
Published in European urology open science (Online) (01.11.2024)
Get full text
Journal Article